Skip to main content
Sign In

Welcome to the Department of Neurology

Neurology Banner Image

Pharmaceutical Search Tool

Clinical Trials

Search for: (view all)

Title Principal Investigator Disease
A Longitudinal, Case-Control Study to Collect Medical and Epidemiological Data and Blood Samples for Research Into the Causes of Multiple Sclerosis and Selected Demyelinating Diseases Vollmer, Timothy L., MD Multiple Sclerosis
An Open-Label, Multicenter Study in Subjects with Relapsing-Remitting Multiple Sclerosis to Evaluate the Safety of 240 mg BG00012 TID Administered as Add-On Therapy to Beta Interferons (IFNΒ) or Glatiramer Acetate (GA) Vollmer, Timothy L., MD Multiple Sclerosis
JCV Antibody Program in Patients with Relapsing Multiple Sclerosis Receiving or Considering Treatment with Tysabri®:STRATIFY-2 Vollmer, Timothy L., MD Multiple Sclerosis
A double-blind randomized, multicenter, placebo-controlled, parallel-group study comparing the efficacy and safety of 0.5 mg FTY720 administered orally once daily versus placebo in patients with primary progressive multiple sclerosis Corboy, John R., MD Multiple Sclerosis
A double-blind, placebo-controlled study of the safety and efficacy of ONO-4641 in patients with relapsing-remitting multiple sclerosis Vollmer, Timothy L., MD Multiple Sclerosis
A phase I open label, dose escalation trial of QPI-1007 delivered by a single intravitreal injection to patients with optic nerve atrophy (stratum I) and acute non-arteritic anterior ischemic optic neuropathy(Naion)(Stratum II) Bennett, Jeffrey L., MD, PhD Optic Nerve Atrophy (Stratum I) and Acute Non-Arteritic Anterior Ischemic Optic Nuropathy(Naion)(Stratum II)
A multinational, multicenter, randomized, parallel-group study performed in subjects with Relapsing-Remitting Multiple Sclerosis(RRMS) to assess the efficacy, safety and tolerability of Glatiramer Acetate (GA) injection 40 mg administered three times a week compared to placebo in a double-blind design Miravalle, Augusto, MD Multiple Sclerosis